Viewing Study NCT05639166


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-01-01 @ 9:52 PM
Study NCT ID: NCT05639166
Status: COMPLETED
Last Update Posted: 2023-05-22
First Post: 2022-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19
Sponsor: Immune Biosolutions Inc
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-02-18
Start Date Type: ACTUAL
Primary Completion Date: 2023-05-16
Primary Completion Date Type: ACTUAL
Completion Date: 2023-05-16
Completion Date Type: ACTUAL
First Submit Date: 2022-12-03
First Submit QC Date: None
Study First Post Date: 2022-12-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-05-18
Last Update Post Date: 2023-05-22
Last Update Post Date Type: ACTUAL